摘要
目的:探讨应用尼尔雌醇雌激素补充治疗(ERT)对绝经后2型糖尿病(T2DM)患者胰岛素抵抗(IR)及脂代谢的影响。方法:30例绝经后妇女T2DM患者,给予尼尔雌醇口服(2mg/2w)6个月作ERT,分别于治疗前后测定空腹血糖(FBG)、胰岛素(FIns)、血脂,稳态模型评估胰岛素抵抗指数(HOMA-IR)、β细胞功能(HOMA-β)、胰岛素敏感指数(ISI),评估胰岛β细胞分泌功能。结果:ERT后FBG、FIns、总胆固醇、甘油三酯、低密度脂蛋白胆固醇、HOMA-IR明显下降;而高密度脂蛋白胆固醇、HOMA-β、ISI明显升高。结论:ERT治疗能明显改善绝经后T2DM患者胰岛素抵抗和血脂紊乱。
Objective:To investigate the effect of nilestriol replacement therapy(ERT) on insulin resistance(IR) and lipid metabolism of type 2 diabetes mellitus(T2DM) in postmenopausal women.Methods:30 cases of postmenopausal women with T2DM were included.Each patient had taken nylestriol(2 mg,twice one month) for 6 months.The levels of serum fasting blood glucose(FBG),fasting insulin(FIns),blood lipid were measured before and after ERT.The assessments of isletβcell function include insulin resistance index(HOM-IR),β-cell function(HOMA-β),insulin sensitivity index(ISI).Results:After ERT,the levels of FBG,FIns,total cholesterol,triglycerides,low density lipoprotein cholesterol,HOMA-IR were decreased obviously,while the levels of high density lipoprotein-cholesterol,HOMA-β,ISI were increased significantly.Conclusion:ERT trERTment can improve insulin resistance and dyslipidemia of T2DM in postmenopausal women.
出处
《赣南医学院学报》
2010年第6期869-870,共2页
JOURNAL OF GANNAN MEDICAL UNIVERSITY
基金
江西省卫生厅课题(编号:20071100)
关键词
雌激素补充治疗
胰岛素抵抗
绝经
2型糖尿病
Estrogen replacement therapy
Insulin resistance
Menopause
Type 2 diabetes mellitus